Healthcare News

STAT+: Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more

Written by David Miller

Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory approvals

Source: STAT News

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]